聯(lián)系電話
- 聯(lián)系人:
- 楊經(jīng)理
- 電話:
- 021-50724187 021-50724961
- 手機(jī):
- 15921799099
- 傳真:
- 021-50724961
- 地址:
- 上海浦東川沙鎮(zhèn)川沙路6619號(hào)上海起發(fā)實(shí)驗(yàn)試劑有限公司
- 個(gè)性化:
- www.qfbio.com
- 網(wǎng)址:
- www.qfbio.com
掃一掃訪問手機(jī)商鋪
世界*實(shí)驗(yàn)材料供應(yīng)商 Cell Guidance Systems 正式授權(quán)上海起發(fā)為其中國(guó)代理, Cell Guidance Systems 在一直是行業(yè)的*,一直為廣大科研客戶提供zui為的產(chǎn)品和服務(wù),上海起發(fā)一直秉承為中國(guó)科研客戶帶來的產(chǎn)品,的服務(wù),簽約 Cell Guidance Systems 就是為了給廣大科研客戶帶來更加完善的產(chǎn)品和服務(wù),您的滿意將是我們zui大的收獲
Cell Guidance Systems 中國(guó)代理, Cell Guidance Systems 上海代理, Cell Guidance Systems 北京代理, Cell Guidance Systems 廣東代理, Cell Guidance Systems 江蘇代理 Cell Guidance Systems 湖北代理, Cell Guidance Systems 天津, Cell Guidance Systems 黑龍江代理, Cell Guidance Systems 內(nèi)蒙古代理, Cell Guidance Systems 吉林代理, Cell Guidance Systems 福建代理, Cell Guidance Systems 江蘇代理, Cell Guidance Systems 浙江代理, Cell Guidance Systems 四川代理,
Cell Guidance Systems位于英國(guó)劍橋。我們成立于2010年,于2011年開設(shè)了美國(guó)辦事處。多年來,我們一直悄然建立起質(zhì)量,服務(wù)和創(chuàng)新的聲譽(yù)。我們是世界上zui激動(dòng)人心的生物技術(shù)區(qū)域之一。我們致力于為世界各地的研究團(tuán)體(包括日本,美國(guó),荷蘭,意大利,新加坡和英國(guó))帶來創(chuàng)新,開發(fā)擴(kuò)大生命科學(xué)研究可能性的產(chǎn)品。我們的許多產(chǎn)品都是真正具有開創(chuàng)性的:例如,ETS-胚胎培養(yǎng)基(在劍橋大學(xué)的Magdalena Zernicka-Goetz教授實(shí)驗(yàn)室開發(fā))能夠從干細(xì)胞中生產(chǎn)人造胚胎。PODS™(在京都理工學(xué)院森山教授實(shí)驗(yàn)室開發(fā))克服了蛋白質(zhì)的穩(wěn)定性限制,為新療法提供了希望。
除了提供試劑和研究服務(wù),我們還參與了基于PODS™技術(shù)的幾個(gè)治療研究領(lǐng)域。我們正在與英國(guó),意大利和日本的研究人員和公司進(jìn)行合作,為各種疾病開發(fā)疫苗和治療藥物。
PODS™ Growth Factors
Standard proteins are extracted from cells using harsh processes that damage the protein, fail to remove impurities (which can have a biological effect) and leave the protein product unprotected from proteases. Although these proteins work instantly, they don't work for long. PODS™ proteins are captured within the cell in a polyhedrin crystal lattice which protects the protein against physical and chemical damage. Once deployed in cell culture, the polyhedrin crystal loosens its grip on the cargo protein providing a sustained release into the local environment. PODS™ crystals provide a depot formulation for sustained protein release over days, weeks and months (when combined with a hydrogel). PODS™ crystals can be attached to surfaces in order to functionalize them and thus create localized concentrations and physiologically relevant gradients.
PODS™生長(zhǎng)因子 產(chǎn)品目錄如下:
貨號(hào) | 品名 |
PPH302-50 | PODS™ Empty, 50 million |
PPH6-50 | PODS™ Human Activin A, 50 million |
PPH6-250 | PODS邃? Human Activin A, 250 million |
PPH6-1000 | PODS™ Human Activin A, 1 billion |
PPM29-50 | PODS™ Mouse Activin A, 50 million |
PPM29-250 | PODS™ Mouse Activin A, 250 million |
PPM29-1000 | PODS™ Mouse Activin A, 1 billion |
PPR6-50 | PODS™ Rat Activin A, 50 million |
PPR6-250 | PODS™ Rat Activin A, 250 million |
PPR6-1000 | PODS™ Rat Activin A, 1 billion |
PPH1-50 | PODS™ Human BDNF, 50 million |
PPH1-250 | PODS™ Human BDNF, 250 million |
PPH1-1000 | PODS™ Human BDNF, 1 billion |
PPH26-50 | PODS™ Human EGF, 50 million |
PPH26-250 | PODS™ Human EGF, 250 million |
PPH26-1000 | PODS™ Human EGF, 1 billion |
PPM301-50 | PODS™ Mouse Ephrin-B2, 50 million |
PPM301-250 | PODS™ Mouse Ephrin-B2, 250 million |
PPM301-1000 | PODS™ Mouse Ephrin-B2, 1 billion |
PPH146-50 | PODS™ Human FGF-2, 50 million |
PPH146-250 | PODS™ Human FGF-2, 250 million |
PPH146-1000 | PODS™ Human FGF-2, 1 billion |
PPH187-50 | PODS™ Human FGF-7, 50 million |
PPH187-250 | PODS™ Human FGF-7, 250 million |
PPH187-1000 | PODS™ Human FGF-7, 1 billion |
PPH2-50 | PODS™ Human GDNF, 50 million |
PPH2-250 | PODS™ Human GDNF, 250 million |
PPH2-1000 | PODS™ Human GDNF, 1 billion |
PPH34-50 | PODS™ Human IGF-1, 50 million |
PPH34-250 | PODS™ Human IGF-1, 250 million |
PPH34-1000 | PODS™ Human IGF-1, 1 billion |
PPH10-50 | PODS™ Human IL-6, 50 million |
PPH10-250 | PODS™ Human IL-6, 250 million |
PPH10-1000 | PODS™ Human IL-6, 1 billion |
PPH10-50 | PODS™ Human IL-6, 50 million |
PPH10-250 | PODS™ Human IL-6, 250 million |
PPH10-1000 | PODS™ Human IL-6, 1 billion |
PPH83-50 | PODS™ Human IL-10, 50 million |
PPH83-250 | PODS™ Human IL-10, 250 million |
PPH83-1000 | PODS™ Human IL-10, 1 billion |
PPH200-50 | PODS™ Human LIF, 50 million |
PPH200-250 | PODS™ Human LIF, 250 million |
PPH200-1000 | PODS™ Human LIF, 1 billion |
PPH18-50 | PODS™ Human PDGF-BB, 50 million |
PPH18-250 | PODS™ Human PDGF-BB, 250 million |
PPH18-1000 | PODS™ Human PDGF-BB, 1 billion |
PPH19-50 | PODS™ Human RANK Ligand, 50 million |
PPH19-250 | PODS™ Human RANK Ligand, 250 million |
PPH19-1000 | PODS™ Human RANK Ligand, 1 billion |
PPH4-50 | PODS™ Human SCF, 50 million |
PPH4-250 | PODS™ Human SCF, 250 million |
PPH4-1000 | PODS™ Human SCF, 1 billion |
PPH168-50 | PODS™ Human SHH, 50 million |
PPH168-250 | PODS™ Human SHH, 250 million |
PPH168-1000 | PODS™ Human SHH, 1 billion |
PPH39-50 | PODS™ Human TGF-β1, 50 million |
PPH39-250 | PODS™ Human TGF-β1, 250 million |
PPH39-1000 | PODS™ Human TGF-β1, 1 billion |
PPH109-50 | PODS™ Human TGF-β3, 50 million |
PPH109-250 | PODS™ Human TGF-β3, 250 million |
PPH109-1000 | PODS™ Human TGF-β3, 1 billion |
PPM34-50 | PODS™ Mouse VEGF-164, 50 million |
PPM34-250 | PODS™ Mouse VEGF-164, 250 million |
PPM34-1000 | PODS™ Mouse VEGF-164, 1 billion |
PPH300-50 | PODS™ Human Wnt-3a, 50 million |
PPH300-250 | PODS™ Human Wnt-3a, 250 million |
PPH300-1000 | PODS™ Human Wnt-3a, 1 billion |